A comparison of gene expression changes in response to diethylstilbestrol treatment in wild-type and p53+/- hemizygous knockout mice using focussed arrays

Toxicology

Volumn 185, Issue 1-2, 2003, Pages 49-57

  Salleh, Mohd Nazil ^a   Caldwell, John ^a   Carmichael, Paul L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Diethylstilbestrol; Macroarrays; P53+ knockout mice

Indexed keywords

CASPASE 2; CASPASE 7; CASPASE 8; CYCLIN D3; DIETHYLSTILBESTROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; NITRIC OXIDE SYNTHASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN MDM2; PROTEIN P15; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN P57;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL CYCLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; GENOTOXICITY; HEMIZYGOSITY; KNOCKOUT MOUSE; LIVER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; WILD TYPE;

ANIMALS; APOPTOSIS; CARCINOGENS; DIETHYLSTILBESTROL; DNA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, P53; HETEROZYGOTE; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0037436413     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00587-5     Document Type: Article

References (35)

1. kip1 levels. Oncogene. 20:2001;2814-2825.
2. Boley S.C., Wong V.A., French J.E., Recio L. p53 heterozygosity altered the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene. Toxicol. Sci. 66:2002;209-215.
3. Bouvard V., Zaitchouk T., Vacher M., Duthu A., Canivet M., Choisy-Rossi C., Nieruchalski M., May E. Tissue and cell-specific expression of the p53-target genes: Bax, Fas, MDM2 and Waf1/p21, before and following ionising irradiation in mice. Oncogene. 19:2000;649-660.
4. Calemine J.B., Gogal R.M., Lengi A., Sponenberg P., Ahmed S.A. Immunomodulation by diethylstilbestrol is dose and gender related: effects on thymocyte apoptosis and mitogen-induced proliferation. Toxicology. 178:2002;101-118.
5. +/- hemizygous knockout mouse: studies with diethylstilbestrol. Toxicol. Pathol. 29:2001;155-160.
6. Clarke A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hooper M.L., Wyllie A.H. Thymocyte apoptosis induced by p53-dependent and p53-independent pathways. Nature. 362:1993;849-852.
7. Dass S.B., Hammons G.J., Bucci T.J., Hefllich R.H., Casciano D.A. Susceptibility of C57BL/6 mice to tumorigenicity induced by dimethylnitrosamine and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the neonatal bioassay. Cancer Lett. 124:1998;105-110.
8. El-Deiry W.S. Regulation of p53 downstream gene. Semin. Cancer Biol. 8:(5):1998;345.
9. El-Deiry W.S., Toniko T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumour suppression. Cell. 75:1993;817-825.
10. El-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Burrell M., Hill D.E., Wang Y.S., Wiman K.G., Mercer W.E., Kastan M.B., Kohn K.W., Elledge S.J., Kinzler K.W., Veglestein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
11. French J.E., Splanding J.W., Dunnick J.K. The use of transgenic animals in cancer testing. Inhal. Toxicol. 11:1999;541-544.
12. Gass G.H., Coats D., Graham N. Carcinogenic dose-response curve to oral diethylstilbestrol. J. Natl. Cancer Inst. 33:1964;971-977.
13. Gottlieb T.M., Oren M. p53 and apoptosis. Semin. Cancer Biol. 8:(5):1998;359-368.
14. Gulezian D., Jacobson-Kram D., McCullough C.B., Olson H., Recio L., Robinson D., Storer R., Tennant R., Ward J.M., Neumann D.A. Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment. Toxicol. Pathol. 26:2000;482-499.
15. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
16. Harvey M., McArthur M.J., Montgomery C.A., Butel J.S., Bradley A., Donehower L.A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet. 5:1993;225-229.
17. Herbst A.L., Ulfelder H., Poskanzer D.C. Adenocarcinoma of the vagina association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284:1971;878-881.
18. Honda R., Tanaka H., Yasuda H. Oncoprotein Mdm2 is a ubiquitin ligase E2 for tumor suppressor p53. FEBS Lett. 420:1997;25-27.
19. Kastan M.B., Onyckwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
20. Linke S.P., Clarkin K.C., Wahl G.M. p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation. Cancer Res. 57:(6):1997;1171-1179.
21. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induced apoptosis in mouse. Nature. 362:1993;786-787.
22. Lu X., Lane D.P. Differential induction of transcriptionally active p53 following UV or ionising radiation: defects in chromosome instability syndromes? Cell. 75:1993;765-778.
23. Marselos M., Tomatis L. Diethylstilbestrol. II. Pharmacology, toxicology and carcinogenicity in humans. Eur. J. Cancer. 29:1993;1182-1189.
24. 32P-postlabeling and the use of pentachlorophenol for a novel metabolic activation pathway of diethylstilbestrol and its dimethyl ether in mouse live: likely alpha-hydroxylation of ethyl group(s) followed by sulfate conjugation. Carcinogenesis. 16:1995;2643-2648.
25. Nelson W.G., Kastan M.B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell Biol. 14:1994;1815-1823.
26. Noller K.L., Fish C.K. Diethylstilbestrol usage; its interesting past, important present and questionable future. Med. Clin. North Am. 58:1974;739-810.
27. Nonclercq D., Zanen J., Toubeau G., Laurent G., Heuson-Stiennon J.A. Apoptosis and cell proliferation in the seminal vesicles and coagulating glands of male Syrian hamsters exposed to diethylstilbestrol (DES). Reprod. Fertil. Dev. 11:1999;111-122.
28. Podust V.N., Podust L.M., Goubin F., Ducommun B., Hubscher U. Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry. 34:(27):1995;8869-8875.
29. Robertson C.N., Robertson K.M., Padilla G.M., O'Brien E.T., Cook J.M., Kim C.S., Fine R.L. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J. Natl. Cancer Inst. 88:1996;908-917.
30. Robinson D. The International Life Sciences Institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk. Toxicol. Pathol. 26:1998;474-475.
31. Shackelford R.E., Kaufmann W.K., Paules R.S. Cell cycle control, checkpoint mechanisms and genotoxic stress. Environ. Health Perspect. 107:(1):1999;5-24.
32. Smith M.L., Zhan Q., Bae I., Fornace A.J. Role of retinoblastoma gene product in p53-mediated DNA damage response. Exp. Cell Res. 215:(2):1994;386-389.
33. Tennant R.W., French J.E., Spalding J.W. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103:1995;942-950.
34. Tennant R.W., Spalding J.W., French J.E. Evaluation of transgenic mouse bioassays for identifying carcinogens and non-carcinogens. Mutat. Res. 365:1996;119-127.
35. Tennant R.W., Stasiewicz S., Mennear J., French J.E., Spalding J.W. Genetically altered mouse models for identifying carcinogens. IARC Sci. Publ. 146:1999;123-150.